Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) current P/S is an impressive 6.34. The overall Semiconductor – Integrated Circuits group has an average P/S ratio of 28.24, which is significantly worse than the sector’s 2.71. In the past 13-year record, this ratio went down as low as 2.82 and as high as 6.58. Also, it is down from 85% of the total 838 rivals across the globe. TSM traded at an unexpectedly high level on 11/28/2017 when the stock experienced a -0.39% loss to a closing price of $40.93. The company saw 4.75 million shares trade hands over the course of the day. Given that its average daily volume over the 30 days has been 4.68 million shares a day, this signifies a pretty significant change over the norm. Analysts are speculating a 7.5% move, based on the high target price ($44) for the shares that is set to reach in the next 12 months. The analysts, on average, are forecasting a $36.22 price target, but the stock is already up 44.42% from its recent lows. However, the stock is trading at -4.86% versus recent highs ($43.02). Analysts believe that we could see stock price minimum in the $28 range (lowest target price), allowing for another -31.59% drop from its current position. Leading up to this report, we have seen a -2.89% fall in the stock price over the last 30 days and a 10.98% increase over the past 3 months. Overall, the share price is up 42.37% so far this year. Additionally, TSM had a day price range of $40.81 to $41.22. Heading into the stock price potential, Taiwan Semiconductor Manufacturing Company Limited by far traveled -12.04% after crossing its median price target of $36. In order to determine directional movement, the 50-day and 200-day moving averages for Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) are $41.56 and $37.65. Given that liquidity is king in short-term, TSM is a stock with 4.88 billion shares outstanding that normally trades 0.66% of its float. The stock price recently experienced a 5-day loss of -3.03% with 0.61 average true range (ATR). TSM has a beta of 0.81 and RSI is 45.25. Investors also need to beware of the Celgene Corporation (NASDAQ:CELG) valuations. The stock trades on a P/S of 6.51, which suggests that the shares are not attractive compared with peers. The broad Biotechnology industry has an average P/S ratio of 3.94, which is significantly better than the sector’s 5.42. In the past 13-year record, this ratio went down as low as 5.37 and as high as 25.21. Also, it is up from 54% of the total 706 rivals across the globe. Celgene Corporation by far traveled 9.98% versus a 1-year low price of $94.5513. The share price was last seen 0.64% higher, reaching at $103.99 on 11/28/2017. At recent session, the prices were hovering between $102.71 and $104.46. This company shares are 19.21% off its target price of $123.97 and the current market capitalization stands at $82.39B. The recent change has given its price a -15.04% deficit over SMA 50 and -29.34% deficit over its 52-week high. The stock witnessed 5.93% gains, -21.48% declines and -9.11% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CELG’s volatility during a week at 1.8% and during a month it has been found around 2.39%. Celgene Corporation (CELG) exchanged hands at an unexpectedly low level of 4.33 million shares over the course of the day. Noting its average daily volume at 6.99 million shares each day over the month, this signifies a pretty significant change over the norm. The market experts are predicting a 59.63% rally, based on the high target price ($166) for Celgene Corporation shares that is likely to be hit in the 52 weeks. Analysts anticipate that traders could see stock price minimum in the $91 range (lowest target price). If faced, it would be a -12.49% drop from its current position. Overall, the share price is down -10.16% year to date.